{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:09:39Z","timestamp":1793394579328,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1743-422x-9-5","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T19:16:30Z","timestamp":1325877390000},"source":"Crossref","is-referenced-by-count":59,"title":["In vitro inhibition of monkeypox virus production and spread by Interferon-\u03b2"],"prefix":"10.1186","volume":"9","author":[{"given":"Sara C","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny L","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Ruthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"key":"1676_CR1","first-page":"2849","volume-title":"Field's Virology","author":"B Moss","year":"2001","unstructured":"Moss B: Poxviridae : the viruses and their replication. In Field's Virology. Volume 2. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott-Raven; 2001:2849-2883.","edition":"4"},{"key":"1676_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jsb.2011.03.010","volume":"175","author":"MW Bahar","year":"2011","unstructured":"Bahar MW, Graham SC, Chen RA, Cooray S, Smith GL, Stuart DI, Grimes JM: How vaccinia virus has evolved to subvert the host immune response. J Struct Biol 2011, 175: 127-134. 10.1016\/j.jsb.2011.03.010","journal-title":"J Struct Biol"},{"key":"1676_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1099\/vir.0.19565-0","volume":"85","author":"C Gubser","year":"2004","unstructured":"Gubser C, Hue S, Kellam P, Smith GL: Poxvirus genomes: a phylogenetic analysis. J Gen Virol 2004, 85: 105-117. 10.1099\/vir.0.19565-0","journal-title":"J Gen Virol"},{"key":"1676_CR4","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1128\/JVI.79.10.6554-6559.2005","volume":"79","author":"SS Jackson","year":"2005","unstructured":"Jackson SS, Ilyinskii P, Philippon V, Gritz L, Yafal AG, Zinnack K, Beaudry KR, Manson KH, Lifton MA, Kuroda MJ, et al.: Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol 2005, 79: 6554-6559. 10.1128\/JVI.79.10.6554-6559.2005","journal-title":"J Virol"},{"key":"1676_CR5","volume-title":"Health Workers Union Wary of Smallpox Vaccinations","author":"LK Altman","year":"2002","unstructured":"Altman LK: Health Workers Union Wary of Smallpox Vaccinations. The New York Times; 2002."},{"key":"1676_CR6","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1001\/jama.281.22.2127","volume":"281","author":"DA Henderson","year":"1999","unstructured":"Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, et al.: Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999, 281: 2127-2137. 10.1001\/jama.281.22.2127","journal-title":"JAMA"},{"key":"1676_CR7","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"41","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, Damon IK, Reynolds MG, Kuehnert MJ: Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis 2005, 41: 1742-1751. 10.1086\/498115","journal-title":"Clin Infect Dis"},{"key":"1676_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/infdis\/156.2.293","volume":"156","author":"Z Jezek","year":"1987","unstructured":"Jezek Z, Szczeniowski M, Paluku KM, Mutombo M: Human monkeypox: clinical features of 282 patients. J Infect Dis 1987, 156: 293-298. 10.1093\/infdis\/156.2.293","journal-title":"J Infect Dis"},{"key":"1676_CR9","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1128\/JCM.40.8.2919-2921.2002","volume":"40","author":"H Meyer","year":"2002","unstructured":"Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, Shungu R, Tshioko F, Formenty P: Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol 2002, 40: 2919-2921. 10.1128\/JCM.40.8.2919-2921.2002","journal-title":"J Clin Microbiol"},{"key":"1676_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/505880","volume":"194","author":"MG Reynolds","year":"2006","unstructured":"Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, Damon IK: Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 2006, 194: 773-780. 10.1086\/505880","journal-title":"J Infect Dis"},{"key":"1676_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-065X.2008.00691.x","volume":"225","author":"JR Weaver","year":"2008","unstructured":"Weaver JR, Isaacs SN: Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev 2008, 225: 96-113. 10.1111\/j.1600-065X.2008.00691.x","journal-title":"Immunol Rev"},{"key":"1676_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0140-6736(86)90748-8","volume":"1","author":"L Khodakevich","year":"1986","unstructured":"Khodakevich L, Jezek Z, Kinzanzka K: Isolation of monkeypox virus from wild squirrel infected in nature. Lancet 1986, 1: 98-99.","journal-title":"Lancet"},{"key":"1676_CR13","first-page":"115","volume":"39","author":"L Khodakevich","year":"1987","unstructured":"Khodakevich L, Szczeniowski M, Manbu ma D, Jezek Z, Marennikova S, Nakano J, Messinger D: The role of squirrels in sustaining monkeypox virus transmission. Trop Geogr Med 1987, 39: 115-122.","journal-title":"Trop Geogr Med"},{"key":"1676_CR14","first-page":"56","volume":"39","author":"L Khodakevich","year":"1987","unstructured":"Khodakevich L, Szczeniowski M, Nambu ma D, Jezek Z, Marennikova S, Nakano J, Meier F: Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire. Trop Geogr Med 1987, 39: 56-63.","journal-title":"Trop Geogr Med"},{"key":"1676_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3201\/eid0703.017311","volume":"7","author":"YJ Hutin","year":"2001","unstructured":"Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, Rodriguez M, Knight JC, Tshioko FK, Khan AS, et al.: Outbreak of human monkeypox, Democratic Republic of Congo, 1996-1997. Emerg Infect Dis 2001, 7: 434-438.","journal-title":"Emerg Infect Dis"},{"key":"1676_CR16","first-page":"73","volume":"40","author":"Z Jezek","year":"1988","unstructured":"Jezek Z, Grab B, Paluku KM, Szczeniowski MV: Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med 1988, 40: 73-83.","journal-title":"Trop Geogr Med"},{"key":"1676_CR17","first-page":"459","volume":"66","author":"Z Jezek","year":"1988","unstructured":"Jezek Z, Grab B, Szczeniowski M, Paluku KM, Mutombo M: Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. Bull World Health Organ 1988, 66: 459-464.","journal-title":"Bull World Health Organ"},{"key":"1676_CR18","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","volume":"107","author":"AW Rimoin","year":"2010","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, Blumberg S, Thomassen HA, Pike BL, Fair JN, et al.: Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA 2010, 107: 16262-16267. 10.1073\/pnas.1005769107","journal-title":"Proc Natl Acad Sci USA"},{"key":"1676_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.virol.2005.05.030","volume":"340","author":"N Chen","year":"2005","unstructured":"Chen N, Li G, Liszewski MK, Atkinson JP, Jahrling PB, Feng Z, Schriewer J, Buck C, Wang C, Lefkowitz EJ, et al.: Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 2005, 340: 46-63. 10.1016\/j.virol.2005.05.030","journal-title":"Virology"},{"key":"1676_CR20","first-page":"593","volume":"46","author":"ID Ladnyj","year":"1972","unstructured":"Ladnyj ID, Ziegler P, Kima E: A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ 1972, 46: 593-597.","journal-title":"Bull World Health Organ"},{"key":"1676_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/NEJMoa032299","volume":"350","author":"KD Reed","year":"2004","unstructured":"Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA, et al.: The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004, 350: 342-350. 10.1056\/NEJMoa032299","journal-title":"N Engl J Med"},{"key":"1676_CR22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4269\/ajtmh.2005.73.428","volume":"73","author":"LA Learned","year":"2005","unstructured":"Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, Stempora LL, Braden ZH, Kline R, Likos A, et al.: Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 2005, 73: 428-434.","journal-title":"Am J Trop Med Hyg"},{"key":"1676_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/smim.1998.0138","volume":"10","author":"CA Biron","year":"1998","unstructured":"Biron CA: Role of early cytokines, including alpha and beta interferons (IFN-alpha\/beta), in innate and adaptive immune responses to viral infections. Semin Immunol 1998, 10: 383-390. 10.1006\/smim.1998.0138","journal-title":"Semin Immunol"},{"key":"1676_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89: 1-47. 10.1099\/vir.0.83391-0","journal-title":"J Gen Virol"},{"key":"1676_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0042-6822(91)90112-O","volume":"183","author":"CE Samuel","year":"1991","unstructured":"Samuel CE: Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991, 183: 1-11. 10.1016\/0042-6822(91)90112-O","journal-title":"Virology"},{"key":"1676_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/jir.2009.0073","volume":"29","author":"B Perdiguero","year":"2009","unstructured":"Perdiguero B, Esteban M: The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res 2009, 29: 581-598. 10.1089\/jir.2009.0073","journal-title":"J Interferon Cytokine Res"},{"key":"1676_CR27","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1073\/pnas.0900452106","volume":"106","author":"MR Mohamed","year":"2009","unstructured":"Mohamed MR, Rahman MM, Lanchbury JS, Shattuck D, Neff C, Dufford M, van Buuren N, Fagan K, Barry M, Smith S, et al.: Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci USA 2009, 106: 9045-9050. 10.1073\/pnas.0900452106","journal-title":"Proc Natl Acad Sci USA"},{"key":"1676_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1006\/viro.1993.1292","volume":"194","author":"HW Chang","year":"1993","unstructured":"Chang HW, Jacobs BL: Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 1993, 194: 537-547. 10.1006\/viro.1993.1292","journal-title":"Virology"},{"key":"1676_CR29","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1073\/pnas.89.11.4825","volume":"89","author":"HW Chang","year":"1992","unstructured":"Chang HW, Watson JC, Jacobs BL: The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 1992, 89: 4825-4829. 10.1073\/pnas.89.11.4825","journal-title":"Proc Natl Acad Sci USA"},{"key":"1676_CR30","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.1073\/pnas.0431131100","volume":"100","author":"YG Kim","year":"2003","unstructured":"Kim YG, Muralinath M, Brandt T, Pearcy M, Hauns K, Lowenhaupt K, Jacobs BL, Rich A: A role for Z-DNA binding in vaccinia virus pathogenesis. Proc Natl Acad Sci USA 2003, 100: 6974-6979. 10.1073\/pnas.0431131100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1676_CR31","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1073\/pnas.0308260100","volume":"101","author":"YG Kim","year":"2004","unstructured":"Kim YG, Lowenhaupt K, Oh DB, Kim KK, Rich A: Evidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: Implications for development of a therapy for poxvirus infection. Proc Natl Acad Sci USA 2004, 101: 1514-1518. 10.1073\/pnas.0308260100","journal-title":"Proc Natl Acad Sci USA"},{"key":"1676_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1128\/JVI.75.2.850-856.2001","volume":"75","author":"TA Brandt","year":"2001","unstructured":"Brandt TA, Jacobs BL: Both carboxy--and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 2001, 75: 850-856. 10.1128\/JVI.75.2.850-856.2001","journal-title":"J Virol"},{"key":"1676_CR33","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1016\/S0021-9258(18)31463-7","volume":"268","author":"K Carroll","year":"1993","unstructured":"Carroll K, Elroy-Stein O, Moss B, Jagus R: Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J Biol Chem 1993, 268: 12837-12842.","journal-title":"J Biol Chem"},{"key":"1676_CR34","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.66.4.1943-1950.1992","volume":"66","author":"MV Davies","year":"1992","unstructured":"Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ: The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1992, 66: 1943-1950.","journal-title":"J Virol"},{"key":"1676_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1432-1033.1997.00085.x","volume":"250","author":"TV Sharp","year":"1997","unstructured":"Sharp TV, Witzel JE, Jagus R: Homologous regions of the alpha subunit of eukaryotic translational initiation factor 2 (eIF2alpha) and the vaccinia virus K3L gene product interact with the same domain within the dsRNA-activated protein kinase (PKR). Eur J Biochem 1997, 250: 85-91. 10.1111\/j.1432-1033.1997.00085.x","journal-title":"Eur J Biochem"},{"key":"1676_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/viro.2002.1479","volume":"299","author":"JO Langland","year":"2002","unstructured":"Langland JO, Jacobs BL: The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 2002, 299: 133-141. 10.1006\/viro.2002.1479","journal-title":"Virology"},{"key":"1676_CR37","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1128\/JVI.01260-09","volume":"83","author":"X Meng","year":"2009","unstructured":"Meng X, Jiang C, Arsenio J, Dick K, Cao J, Xiang Y: Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons. J Virol 2009, 83: 10627-10636. 10.1128\/JVI.01260-09","journal-title":"J Virol"},{"issue":"Pt 7","key":"1676_CR38","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1099\/0022-1317-74-7-1409","volume":"74","author":"N Oguiura","year":"1993","unstructured":"Oguiura N, Spehner D, Drillien R: Detection of a protein encoded by the vaccinia virus C7L open reading frame and study of its effect on virus multiplication in different cell lines. J Gen Virol 1993,74(Pt 7):1409-1413.","journal-title":"J Gen Virol"},{"key":"1676_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0042-6822(90)90296-4","volume":"179","author":"ME Perkus","year":"1990","unstructured":"Perkus ME, Goebel SJ, Davis SW, Johnson GP, Limbach K, Norton EK, Paoletti E: Vaccinia virus host range genes. Virology 1990, 179: 276-286. 10.1016\/0042-6822(90)90296-4","journal-title":"Virology"},{"key":"1676_CR40","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1128\/JVI.78.7.3553-3560.2004","volume":"78","author":"JL Shisler","year":"2004","unstructured":"Shisler JL, Jin XL: The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 2004, 78: 3553-3560. 10.1128\/JVI.78.7.3553-3560.2004","journal-title":"J Virol"},{"key":"1676_CR41","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1099\/vir.0.015347-0","volume":"91","author":"S Backes","year":"2010","unstructured":"Backes S, Sperling KM, Zwilling J, Gasteiger G, Ludwig H, Kremmer E, Schwantes A, Staib C, Sutter G: Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation factor 2alpha. J Gen Virol 2010, 91: 470-482. 10.1099\/vir.0.015347-0","journal-title":"J Gen Virol"},{"key":"1676_CR42","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1096\/fj.09-144733","volume":"24","author":"M Fernandez de Marco Mdel","year":"2010","unstructured":"Fernandez de Marco Mdel M, Alejo A, Hudson P, Damon IK, Alcami A: The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon. FASEB J 2010, 24: 1479-1488. 10.1096\/fj.09-144733","journal-title":"FASEB J"},{"key":"1676_CR43","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.4049\/jimmunol.180.11.7158","volume":"180","author":"SL Day","year":"2008","unstructured":"Day SL, Ramshaw IA, Ramsay AJ, Ranasinghe C: Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy. J Immunol 2008, 180: 7158-7166.","journal-title":"J Immunol"},{"key":"1676_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1099\/0022-1317-48-1-25","volume":"48","author":"W Weimar","year":"1980","unstructured":"Weimar W, Stitz L, Billiau A, Cantell K, Schellekens H: Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon. J Gen Virol 1980, 48: 25-30. 10.1099\/0022-1317-48-1-25","journal-title":"J Gen Virol"},{"key":"1676_CR45","doi-asserted-by":"publisher","first-page":"28419","DOI":"10.1074\/jbc.R110.145839","volume":"285","author":"O Haller","year":"2010","unstructured":"Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G: Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J Biol Chem 2010, 285: 28419-28424. 10.1074\/jbc.R110.145839","journal-title":"J Biol Chem"},{"key":"1676_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jir.2010.0076","volume":"31","author":"O Haller","year":"2010","unstructured":"Haller O, Kochs G: Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 2010, 31: 79-87.","journal-title":"J Interferon Cytokine Res"},{"key":"1676_CR47","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.micinf.2007.09.010","volume":"9","author":"O Haller","year":"2007","unstructured":"Haller O, Stertz S, Kochs G: The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect 2007, 9: 1636-1643. 10.1016\/j.micinf.2007.09.010","journal-title":"Microbes Infect"},{"key":"1676_CR48","first-page":"73","volume":"71","author":"O Haller","year":"2009","unstructured":"Haller O, Weber F: The interferon response circuit in antiviral host defense. Verh K Acad Geneeskd Belg 2009, 71: 73-86.","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"1676_CR49","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1128\/JVI.00781-08","volume":"83","author":"CL Netherton","year":"2009","unstructured":"Netherton CL, Simpson J, Haller O, Wileman TE, Takamatsu HH, Monaghan P, Taylor G: Inhibition of a large double-stranded DNA virus by MxA protein. J Virol 2009, 83: 2310-2320. 10.1128\/JVI.00781-08","journal-title":"J Virol"},{"key":"1676_CR50","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/JVI.64.7.3370-3375.1990","volume":"64","author":"J Pavlovic","year":"1990","unstructured":"Pavlovic J, Zurcher T, Haller O, Staeheli P: Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 1990, 64: 3370-3375.","journal-title":"J Virol"},{"key":"1676_CR51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JVI.58.3.967-969.1986","volume":"58","author":"P Staeheli","year":"1986","unstructured":"Staeheli P, Pravtcheva D, Lundin LG, Acklin M, Ruddle F, Lindenmann J, Haller O: Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J Virol 1986, 58: 967-969.","journal-title":"J Virol"},{"key":"1676_CR52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1089\/jir.2006.26.650","volume":"26","author":"S Stertz","year":"2006","unstructured":"Stertz S, Reichelt M, Krijnse-Locker J, Mackenzie J, Simpson JC, Haller O, Kochs G: Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum. J Interferon Cytokine Res 2006, 26: 650-660. 10.1089\/jir.2006.26.650","journal-title":"J Interferon Cytokine Res"},{"key":"1676_CR53","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1128\/JVI.69.6.3904-3909.1995","volume":"69","author":"M Frese","year":"1995","unstructured":"Frese M, Kochs G, Meier-Dieter U, Siebler J, Haller O: Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol 1995, 69: 3904-3909.","journal-title":"J Virol"},{"key":"1676_CR54","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/j.1460-2075.1992.tb05212.x","volume":"11","author":"T Zurcher","year":"1992","unstructured":"Zurcher T, Pavlovic J, Staeheli P: Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J 1992, 11: 1657-1661.","journal-title":"EMBO J"},{"key":"1676_CR55","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/AAC.00021-09","volume":"53","author":"J Huggins","year":"2009","unstructured":"Huggins J, Goff A, Hensley L, Mucker E, Shamblin J, Wlazlowski C, Johnson W, Chapman J, Larsen T, Twenhafel N, et al.: Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 2009, 53: 2620-2625. 10.1128\/AAC.00021-09","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"1676_CR56","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1016\/j.vaccine.2009.07.103","volume":"27","author":"RB Kennedy","year":"2009","unstructured":"Kennedy RB, Ovsyannikova I, Poland GA: Smallpox vaccines for biodefense. Vaccine 2009,27(Suppl 4):D73-79.","journal-title":"Vaccine"},{"key":"1676_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","volume":"25","author":"I Wiser","year":"2007","unstructured":"Wiser I, Balicer RD, Cohen D: An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Vaccine 2007, 25: 976-984. 10.1016\/j.vaccine.2006.09.046","journal-title":"Vaccine"},{"key":"1676_CR58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/j.1553-2712.2003.tb00043.x","volume":"10","author":"WW Everett","year":"2003","unstructured":"Everett WW, Coffin SE, Zaoutis T, Halpern SD, Strom BL: Smallpox vaccination: a national survey of emergency health care providers. Acad Emerg Med 2003, 10: 606-611.","journal-title":"Acad Emerg Med"},{"key":"1676_CR59","volume-title":"When parents say no to child vaccinations","author":"D McNeil","year":"2002","unstructured":"McNeil D: When parents say no to child vaccinations. The New York Times; 2002."},{"key":"1676_CR60","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/clpt.2010.178","volume":"88","author":"LK Dropulic","year":"2010","unstructured":"Dropulic LK, Cohen JI: Update on new antivirals under development for the treatment of double-stranded DNA virus infections. Clin Pharmacol Ther 2010, 88: 610-619. 10.1038\/clpt.2010.178","journal-title":"Clin Pharmacol Ther"},{"key":"1676_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","volume":"57","author":"RO Baker","year":"2003","unstructured":"Baker RO, Bray M, Huggins JW: Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Res 2003, 57: 13-23. 10.1016\/S0166-3542(02)00196-1","journal-title":"Antiviral Res"},{"key":"1676_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0166-3542(01)00159-0","volume":"52","author":"DF Smee","year":"2001","unstructured":"Smee DF, Bailey KW, Wong MH, Sidwell RW: Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. Antiviral Res 2001, 52: 55-62. 10.1016\/S0166-3542(01)00159-0","journal-title":"Antiviral Res"},{"key":"1676_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature04295","volume":"439","author":"KJ Stittelaar","year":"2006","unstructured":"Stittelaar KJ, Neyts J, Naesens L, van Amerongen G, van Lavieren RF, Holy A, De Clercq E, Niesters HG, Fries E, Maas C, et al.: Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature 2006, 439: 745-748. 10.1038\/nature04295","journal-title":"Nature"},{"key":"1676_CR64","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/156652405774962326","volume":"5","author":"PB Jahrling","year":"2005","unstructured":"Jahrling PB, Fritz EA, Hensley LE: Countermeasures to the bioterrorist threat of smallpox. Curr Mol Med 2005, 5: 817-826. 10.2174\/156652405774962326","journal-title":"Curr Mol Med"},{"key":"1676_CR65","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1265","volume":"11","author":"PM Reeves","year":"2005","unstructured":"Reeves PM, Bommarius B, Lebeis S, McNulty S, Christensen J, Swimm A, Chahroudi A, Chavan R, Feinberg MB, Veach D, et al.: Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat Med 2005, 11: 731-739. 10.1038\/nm1265","journal-title":"Nat Med"},{"key":"1676_CR66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1358\/dot.2010.46.2.1437244","volume":"46","author":"TC Bolken","year":"2010","unstructured":"Bolken TC, Hruby DE: Tecovirimat for smallpox infections. Drugs Today (Barc) 2010, 46: 109-117. 10.1358\/dot.2010.46.2.1437244","journal-title":"Drugs Today (Barc)"},{"key":"1676_CR67","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1128\/JVI.02525-10","volume":"85","author":"AJ Goff","year":"2011","unstructured":"Goff AJ, Chapman J, Foster C, Wlazlowski C, Shamblin J, Lin K, Kreiselmeier N, Mucker E, Paragas J, Lawler J, Hensley L: A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. J Virol 2011, 85: 4898-4909. 10.1128\/JVI.02525-10","journal-title":"J Virol"},{"key":"1676_CR68","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/AAC.01596-08","volume":"53","author":"R Jordan","year":"2009","unstructured":"Jordan R, Goff A, Frimm A, Corrado ML, Hensley LE, Byrd CM, Mucker E, Shamblin J, Bolken TC, Wlazlowski C, et al.: ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother 2009, 53: 1817-1822. 10.1128\/AAC.01596-08","journal-title":"Antimicrob Agents Chemother"},{"key":"1676_CR69","doi-asserted-by":"publisher","first-page":"4802","DOI":"10.1128\/JVI.75.10.4802-4813.2001","volume":"75","author":"BM Ward","year":"2001","unstructured":"Ward BM, Moss B: Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera. J Virol 2001, 75: 4802-4813. 10.1128\/JVI.75.10.4802-4813.2001","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-9-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-9-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T09:49:28Z","timestamp":1640425768000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-9-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,6]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-9-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,6]]},"article-number":"5"}}